Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2007 Aug;22(4):687-92.
doi: 10.3346/jkms.2007.22.4.687.

Survival rate changes in neonates with congenital diaphragmatic hernia and its contributing factors

Do Hyun Kim  1 , June Dong Park, Han Suk Kim, So Yeon Shim, Ee Kyung Kim, Beyong Il Kim, Jung Hwan Choi, Gui Won Park
Affiliations
Clinical Trial

Survival rate changes in neonates with congenital diaphragmatic hernia and its contributing factors

Do Hyun Kim et al. J Korean Med Sci. 2007 Aug.

Abstract

The purpose of this study was to demonstrate survival rate changes after the introduction of inhaled nitric oxide (iNO) therapy, and to identify the factors that influence these changes in neonates with a congenital diaphragmatic hernia (CDH) at a single center. A total of 48 neonates were divided into two groups based on the time of admission, i.e., into period I (P1; n=17; before the introduction of iNO therapy) and period II (P2; n=31; after the introduction of iNO therapy). Survival rates of the 48 neonates showed a tendency to increase from 53% during P1 to 77% during P2, but without a statistical significance, but a significant difference was found between survival rates during the two periods after adjusting for initial clinical characteristics, when the postoperative survival rate increased significantly from 69% for P1 to 100% for P2. The mean duration of preoperative respiratory management was significantly longer for P2 than for P1. Seven of 12 patients who received preoperative iNO therapy due to persistent pulmonary hypertension or refractory preductal hypoxemia in P2 survived after operation. We speculate that a management strategy based on iNO therapy and delayed operation, rather than differences between the initial clinical characteristics of the two study groups, might partially contribute to the observed improvements in postoperative and overall survival rates in neonates with CDH.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow diagram showing the courses and outcomes of the 55 patients with congenital diaphragmatic hernia (CDH) enrolled in this study. NICU, neonatal intensive care unit.
Fig. 2
Fig. 2
Outcomes of pre- and postoperative iNO therapy for neonates with congenital diaphragmatic hernia during period II.
See this image and copyright information in PMC

References

    1. Weinstein S, Stolar CJ. Newborn surgical emergency, congenital diaphragmatic hernia and extracorporeal membrane oxygenation. Pediatr Clin North Am. 1993;40:1315–1333. - PubMed
    1. Clark RH, Hardin WD, Jr, Hirschl RB, Jaksic T, Lally KP, Langham MR, Jr, Wilson JM. Current surgical management of congenital diaphragmatic hernia: a report from the congenital diaphragmatic hernia study group. J Pediatr Surg. 1998;33:1004–1009. - PubMed
    1. Beresford MW, Shaw NJ. Outcome of congenital diaphragmatic hernia. Pediatr Pulmonol. 2000;30:249–256. - PubMed
    1. The Congenital Diaphragmatic Hernia Study Group. Estimating disease severity of congenital diaphragmatic hernia in the first 5 minutes of life. J Pediatr Surg. 2001;36:141–145. - PubMed
    1. The Neonatal Inhaled Nitric Oxide Study Group (NINOSG) NINOSG). Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics. 1997;99:838–845. - PubMed

Publication types